The glycoprotein 5 (GP5) of porcine reproductive and respiratory syndrome virus (PRRSV) is a multi-functional protein that plays important roles in virus assembly, entry and viral anti-host responses. In the present study, we investigated the cellular binding partners of GP5 by using lentivirus transduction coupled with immunoprecipitation and mass spectrometry. There were about 40 cellular proteins identified with high Confidence Icons by MS/MS. Ingenuity Pathway Analysis (IPA) indicated that these proteins could be assigned to different functional classes and networks. Furthermore, we validated some of the interactions by co-immunoprecipitation (Co-IP) and confocal microscopy, including those with mitofilin, a mitochondrial inner membrane protein that might be involved in PRRSV or GP5-induced apoptosis, and calnexin, a protein chaperone that might facilitate the folding and maturation of GP5. The interactome data contribute to understand the role and molecular mechanisms of GP5 in PRRSV pathogenesis.

We studied the effect of baicalin, an extract from Radix Scutellariae (a traditional Chinese medicine) in inducing mouse pulmonary microvascular endothelial cells (MPMVECs) to produce interferons (IFNs). MPMVECs were cultured in vitro in the presence of different concentrations of baicalin (10, 20, and 30 μg mL-1), and the cells and the culture media were harvested at various time intervals. The proteins and mRNA levels (relative to β-actin) of IFN-α/β and IFN-γ were analyzed by RT-PCR and enzyme-linked immunosorbent assay (ELISA). It was observed that baicalin substantially up-regulated the expression of IFN-α/β and IFN-γ. In all baicalin-treated groups, the relative levels of IFN-α/β and IFN-γ mRNAs peaked after 12 h of culturing, and IFN-α/β and IFN-γ proteins peaked after 24 h of culturing. These results suggest that baicalin can effectively induce the expression of IFNs in pulmonary microvascular endothelial cells, and thus potentially act as an antiviral compound. This study may provide background information for developing new antiviral drugs based on baicalin.